These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26745041)

  • 1. Sarcopenia in Cancer Patients.
    Chindapasirt J
    Asian Pac J Cancer Prev; 2015; 16(18):8075-7. PubMed ID: 26745041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of Sarcopenia on Gastric Cancer.
    Kuwada K; Kuroda S; Kikuchi S; Yoshida R; Nishizaki M; Kagawa S; Fujiwara T
    Anticancer Res; 2019 May; 39(5):2241-2249. PubMed ID: 31092415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance.
    Guinan EM; Doyle SL; Bennett AE; O'Neill L; Gannon J; Elliott JA; O'Sullivan J; Reynolds JV; Hussey J
    Support Care Cancer; 2018 May; 26(5):1569-1576. PubMed ID: 29197960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index.
    Choi Y; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
    PLoS One; 2015; 10(10):e0139749. PubMed ID: 26437072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
    BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
    Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
    Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sarcopenia in the management of urological cancer patients.
    Fukushima H; Koga F
    Expert Rev Anticancer Ther; 2017 May; 17(5):455-466. PubMed ID: 28271727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and Molecular Basis of Sarcopenia: Implications in the Management of Urothelial Carcinoma.
    Fukushima H; Fujii Y; Koga F
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors related to sarcopenia in community-dwelling elderly subjects in Japan].
    Tanimoto Y; Watanabe M; Sugiura Y; Hayashida I; Kusabiraki T; Kono K
    Nihon Koshu Eisei Zasshi; 2013; 60(11):683-90. PubMed ID: 24418916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CT-determined sarcopenia in patients with advanced gastric cancer.
    Lee JS; Kim YS; Kim EY; Jin W
    PLoS One; 2018; 13(8):e0202700. PubMed ID: 30125312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer.
    Sugiyama K; Narita Y; Mitani S; Honda K; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Ando M; Tajika M; Muro K
    Anticancer Res; 2018 Oct; 38(10):5859-5866. PubMed ID: 30275211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
    Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
    Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke-related sarcopenia: specific characteristics.
    Scherbakov N; Sandek A; Doehner W
    J Am Med Dir Assoc; 2015 Apr; 16(4):272-6. PubMed ID: 25676847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia in gastric cancer: when the loss costs too much.
    Ongaro E; Buoro V; Cinausero M; Caccialanza R; Turri A; Fanotto V; Basile D; Vitale MG; Ermacora P; Cardellino GG; Nicoletti L; Fornaro L; Casadei-Gardini A; Aprile G
    Gastric Cancer; 2017 Jul; 20(4):563-572. PubMed ID: 28477106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.
    Bozzetti F
    Ann Oncol; 2017 Sep; 28(9):2107-2118. PubMed ID: 28911059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer.
    Fukushima H; Takemura K; Suzuki H; Koga F
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Cutoff Values of Skeletal Muscle Index to Define Sarcopenia for Prediction of Survival in Patients with Advanced Gastric Cancer.
    Nishigori T; Tsunoda S; Obama K; Hisamori S; Hashimoto K; Itatani Y; Okada K; Sakai Y
    Ann Surg Oncol; 2018 Nov; 25(12):3596-3603. PubMed ID: 30167910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posttherapeutic skeletal muscle mass recovery predicts favorable prognosis in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
    Fukushima H; Kataoka M; Nakanishi Y; Sakamoto K; Takemura K; Suzuki H; Ito M; Tobisu KI; Fujii Y; Koga F
    Urol Oncol; 2018 Apr; 36(4):156.e9-156.e16. PubMed ID: 29051030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.